Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 1.32 billion. The enterprise value is 2.55 billion.
Important Dates
The next estimated earnings date is Friday, March 12, 2027.
| Earnings Date | Mar 12, 2027 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
Synbio Tech has 34.47 million shares outstanding. The number of shares has increased by 7.35% in one year.
| Current Share Class | 34.47M |
| Shares Outstanding | 34.47M |
| Shares Change (YoY) | +7.35% |
| Shares Change (QoQ) | +4.49% |
| Owned by Insiders (%) | 34.10% |
| Owned by Institutions (%) | n/a |
| Float | 13.48M |
Valuation Ratios
The trailing PE ratio is 10.35.
| PE Ratio | 10.35 |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.43 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 19.74 |
| EV / Sales | 2.48 |
| EV / EBITDA | 9.70 |
| EV / EBIT | 19.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.00.
| Current Ratio | 1.27 |
| Quick Ratio | 0.53 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 5.59 |
| Debt / FCF | n/a |
| Interest Coverage | 4.00 |
Financial Efficiency
Return on equity (ROE) is 9.41% and return on invested capital (ROIC) is 5.09%.
| Return on Equity (ROE) | 9.41% |
| Return on Assets (ROA) | 2.75% |
| Return on Invested Capital (ROIC) | 5.09% |
| Return on Capital Employed (ROCE) | 5.29% |
| Weighted Average Cost of Capital (WACC) | 4.40% |
| Revenue Per Employee | 11.18M |
| Profits Per Employee | 1.40M |
| Employee Count | 92 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, Synbio Tech has paid 9.15 million in taxes.
| Income Tax | 9.15M |
| Effective Tax Rate | 6.62% |
Stock Price Statistics
The stock price has decreased by -59.14% in the last 52 weeks. The beta is 0.49, so Synbio Tech's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -59.14% |
| 50-Day Moving Average | 45.52 |
| 200-Day Moving Average | 54.69 |
| Relative Strength Index (RSI) | 18.83 |
| Average Volume (20 Days) | 36,324 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.03 billion and earned 129.07 million in profits. Earnings per share was 3.69.
| Revenue | 1.03B |
| Gross Profit | 513.90M |
| Operating Income | 132.70M |
| Pretax Income | 138.22M |
| Net Income | 129.07M |
| EBITDA | 259.24M |
| EBIT | 132.70M |
| Earnings Per Share (EPS) | 3.69 |
Full Income Statement Balance Sheet
The company has 236.81 million in cash and 1.47 billion in debt, with a net cash position of -1.23 billion or -35.72 per share.
| Cash & Cash Equivalents | 236.81M |
| Total Debt | 1.47B |
| Net Cash | -1.23B |
| Net Cash Per Share | -35.72 |
| Equity (Book Value) | 1.47B |
| Book Value Per Share | 40.85 |
| Working Capital | 181.57M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 204.95 million and capital expenditures -363.60 million, giving a free cash flow of -158.65 million.
| Operating Cash Flow | 204.95M |
| Capital Expenditures | -363.60M |
| Depreciation & Amortization | 126.54M |
| Net Borrowing | 138.36M |
| Free Cash Flow | -158.65M |
| FCF Per Share | -4.60 |
Full Cash Flow Statement Margins
Gross margin is 49.96%, with operating and profit margins of 12.90% and 12.55%.
| Gross Margin | 49.96% |
| Operating Margin | 12.90% |
| Pretax Margin | 13.44% |
| Profit Margin | 12.55% |
| EBITDA Margin | 25.20% |
| EBIT Margin | 12.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 7.85%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 7.85% |
| Dividend Growth (YoY) | -39.64% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 80.13% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.35% |
| Shareholder Yield | 0.51% |
| Earnings Yield | 9.66% |
| FCF Yield | -12.05% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 1.62 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 5 |